Tapias Filho Antonio Haddad, Oliveira Gustavo Bernardes de Figueiredo, França João Italo Dias, Ramos Rui Fernando
Instituto Dante Pazzanese de Cardiologia, São Paulo, SP - Brasil.
Arq Bras Cardiol. 2022 May 9;118(6):1006-15. doi: 10.36660/abc.20210191.
Contemporary diagnosis of ACS and risk stratification are essential for appropriate management and reduction of mortality and recurrent ischemic events, in the acute phase of disease and after hospitalization. The Universal Definition of Myocardial Infarction recommends the detection of troponin levels above the 99th percentile.
To evaluate the occurrence of early death and acute myocardial infarction (AMI) in patients without elevation of troponin (<0.034 ng/mL), patients with mild elevation (above the 99th percentile [>0.034 ng/mL and <0.12 ng/mL)], and patients with significant elevation of troponin (above the diagnostic cutoff for AMI defined by the troponin kit (≥0.12 ng/mL)]; and to analyze the impact of troponin on the indication for invasive strategy and myocardial revascularization.
Cross-sectional cohort study of patients with ACS with assessment of peak troponin I, risk score, prospective analysis of 30-day clinical outcomes and two-sided statistical tests, with statistical significance set at p<0.05.
A total of 494 patients with ACS were evaluated. Troponin > 99th percentile and below the cutoff point, as well as values above the cutoff, were associated with higher incidence of composite endpoint (p<0.01) and higher rates of percutaneous or surgical revascularization procedures (p<0.01), without significative difference in 30-day mortality.
Troponin levels above the 99th percentile defined by the universal definition of AMI play a prognostic role and add useful information to the clinical diagnosis and risk scores by identifying those patients who would most benefit from invasive risk stratification and coronary revascularization procedures.
在疾病急性期及住院后,当代对急性冠状动脉综合征(ACS)的诊断和风险分层对于恰当的治疗管理以及降低死亡率和复发性缺血事件至关重要。《心肌梗死通用定义》推荐检测肌钙蛋白水平高于第99百分位数。
评估肌钙蛋白未升高(<0.034 ng/mL)、轻度升高(高于第99百分位数[>0.034 ng/mL且<0.12 ng/mL])以及显著升高(高于肌钙蛋白检测试剂盒定义的急性心肌梗死(AMI)诊断临界值[≥0.12 ng/mL])的患者中早期死亡和急性心肌梗死(AMI)的发生率;并分析肌钙蛋白对侵入性策略指征和心肌血运重建的影响。
对ACS患者进行横断面队列研究,评估肌钙蛋白I峰值、风险评分,对30天临床结局进行前瞻性分析并进行双侧统计检验,设定统计学显著性为p<0.05。
共评估了494例ACS患者。肌钙蛋白高于第99百分位数且低于临界值以及高于临界值,均与复合终点发生率较高(p<0.01)和经皮或外科血运重建手术率较高(p<0.01)相关,30天死亡率无显著差异。
AMI通用定义所定义的高于第99百分位数的肌钙蛋白水平具有预后作用,通过识别那些最能从侵入性风险分层和冠状动脉血运重建手术中获益的患者,为临床诊断和风险评分增添有用信息。